ReviewIndian journal of ophthalmology2026
Laser peripheral iridotomy induced changes in eyes with primary angle closure disease.
Review in Indian journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary angle closure disease (PACD) though less prevalent than primary open angle glaucoma contributes to fifty percent of glaucoma blindness, particularly in the Asian population. Pupillary block is the most common pathology associated with PACD. The definitive treatment to relieve pupillary block and to prevent disease progression is laser peripheral iridotomy (LPI). The most commonly employed laser for performing laser peripheral iridotomy is Neodymium: Yttrium Aluminium Garnet (Nd:YAG). LPI is routinely performed as an outpatient procedure. Though it is often considered as a safe procedure, it is not without limitations. Apart from widening the angle it can influence the intraocular pressure, corneal endothelial cells and can lead to newer visual disturbances/dysphotopsias. Additionally, it can cause or accelerate cataract formation. This narrative review discusses the indications, procedural considerations, structural and functional outcomes, and the changes associated with LPI in eyes with PACD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.